Rafael Ríos

1.2k total citations
37 papers, 594 citations indexed

About

Rafael Ríos is a scholar working on Infectious Diseases, Molecular Medicine and Epidemiology. According to data from OpenAlex, Rafael Ríos has authored 37 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 17 papers in Molecular Medicine and 11 papers in Epidemiology. Recurrent topics in Rafael Ríos's work include Antimicrobial Resistance in Staphylococcus (19 papers), Antibiotic Resistance in Bacteria (17 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Rafael Ríos is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (19 papers), Antibiotic Resistance in Bacteria (17 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). Rafael Ríos collaborates with scholars based in Colombia, United States and Chile. Rafael Ríos's co-authors include Lorena Díaz, César A. Arias, Truc T. Tran, Jinnethe Reyes, An Q Dinh, José M. Munita, William R. Miller, Lina P Carvajal, Diana Panesso and Elsa De La Cadena and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Infectious Diseases.

In The Last Decade

Rafael Ríos

34 papers receiving 590 citations

Peers

Rafael Ríos
Xiang Sun China
Keren Shi China
Jill S. Garlick Australia
Akio Kuga Japan
Rafael Ríos
Citations per year, relative to Rafael Ríos Rafael Ríos (= 1×) peers Feng-Jui Chen

Countries citing papers authored by Rafael Ríos

Since Specialization
Citations

This map shows the geographic impact of Rafael Ríos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Ríos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Ríos more than expected).

Fields of papers citing papers by Rafael Ríos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Ríos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Ríos. The network helps show where Rafael Ríos may publish in the future.

Co-authorship network of co-authors of Rafael Ríos

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Ríos. A scholar is included among the top collaborators of Rafael Ríos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Ríos. Rafael Ríos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ortega-Paredes, David, Felipe Del Canto, Rafael Ríos, et al.. (2025). Genomic Insights into Colistin and Tigecycline Resistance in ESBL-Producing Escherichia coli and Klebsiella pneumoniae Harboring blaKPC Genes in Ecuador. Antibiotics. 14(2). 206–206.
2.
Tran, Truc T., Anne J Gonzales-Luna, Travis J Carlson, et al.. (2022). Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA. JAC-Antimicrobial Resistance. 5(1). dlac131–dlac131. 3 indexed citations
3.
Cadena, Elsa De La, Rafael Ríos, Lorena Díaz, et al.. (2022). Molecular mechanisms leading to ceftolozane/tazobactam resistance in clinical isolates of Pseudomonas aeruginosa from five Latin American countries. Frontiers in Microbiology. 13. 1035609–1035609. 7 indexed citations
4.
Rubia, Javier de la, Rafael Alonso, Alfonso García de Coca, et al.. (2022). Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma Included in the Compassionate Use or the Expanded Access Program. Experience with a Spanish Cohort. Blood. 140(Supplement 1). 4315–4317. 4 indexed citations
5.
Ríos, Rafael, Lina P Carvajal, Mónica P. Cala, et al.. (2022). Multiomics characterization of methicillin-resistant Staphylococcus aureus (MRSA) isolates with heterogeneous intermediate resistance to vancomycin (hVISA) in Latin America. Journal of Antimicrobial Chemotherapy. 78(1). 122–132. 7 indexed citations
6.
Ríos, Rafael, Jinnethe Reyes, Lina P Carvajal, et al.. (2020). Genomic Epidemiology of Vancomycin-Resistant Enterococcus faecium (VREfm) in Latin America: Revisiting The Global VRE Population Structure. Scientific Reports. 10(1). 5636–5636. 38 indexed citations
7.
Ríos, Rafael, et al.. (2020). A Young Diabetic Patient With Sepsis After Gardening. Open Forum Infectious Diseases. 7(5). ofaa159–ofaa159. 3 indexed citations
8.
Rodríguez, José Yesid, et al.. (2020). Case Report: Gestational Melioidosis through Perinatal Transmission. American Journal of Tropical Medicine and Hygiene. 103(5). 1838–1840. 4 indexed citations
9.
Cadena, Elsa De La, Carlos A. Agudelo, An Q Dinh, et al.. (2020). Dynamics of bla KPC-2 Dissemination from Non-CG258 Klebsiella pneumoniae to Other Enterobacterales via IncN Plasmids in an Area of High Endemicity. Antimicrobial Agents and Chemotherapy. 64(12). 34 indexed citations
10.
Khan, Ayesha, Truc T. Tran, Rafael Ríos, et al.. (2019). Extensively Drug-Resistant Pseudomonas aeruginosa ST309 Harboring Tandem Guiana Extended Spectrum β-Lactamase Enzymes: A Newly Emerging Threat in the United States. Open Forum Infectious Diseases. 6(7). ofz273–ofz273. 40 indexed citations
11.
Mojica, María F., Rafael Ríos, Elsa De La Cadena, et al.. (2019). 612. Molecular Mechanisms Leading to Ceftolozane–Tazobactam Resistance in Clinical Isolates of Pseudomonas aeruginosa from Five Latin American Countries.. Open Forum Infectious Diseases. 6. 1 indexed citations
12.
Tran, Truc T., Diana Panesso, Lorena Díaz, Rafael Ríos, & César A. Arias. (2019). 601. TelA and XpaC Are Novel Mediators of Daptomycin Resistance in Enterococcus faecium. Open Forum Infectious Diseases. 6(Supplement_2). S282–S282. 1 indexed citations
13.
Ríos, Rafael, et al.. (2019). Circulating miR‑141‑3p, miR‑143‑3p and miR‑200c‑3p are differentially expressed in colorectal cancer and advanced adenomas. Molecular and Clinical Oncology. 11(2). 201–207. 35 indexed citations
14.
Abodakpi, Henrietta, Rafael Ríos, Lorena Díaz, et al.. (2018). In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways. SHILAP Revista de lepidopterología. 2018. 1–4. 20 indexed citations
15.
Cadena, Elsa De La, Cristhian Hernández-Gómez, Christian Pallares, et al.. (2017). Plasmid Promiscuity Explains High Endemicity of KPC-2 Among Colombian Enterobacteriaceae. Open Forum Infectious Diseases. 4(suppl_1). S602–S603.
16.
Miller, William R., Rafael Ríos, Lorena Díaz, et al.. (2017). Co-occurrence of NDM-5, OXA-181, and CMY-2 in a Clinical E. coli Isolate From a Patient in the United States. Open Forum Infectious Diseases. 4(suppl_1). S128–S128. 2 indexed citations
17.
Tran, Truc T., Lorena Díaz, Henrietta Abodakpi, et al.. (2017). Ceftolozane-Tazobactam Resistance in Multidrug-Resistant Pseudomonas aeruginosa Isolates Not Associated with AmpC Activity. Open Forum Infectious Diseases. 4(suppl_1). S127–S128. 1 indexed citations
18.
Nigo, Masayuki, Lorena Díaz, Lina P Carvajal, et al.. (2017). Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis. Antimicrobial Agents and Chemotherapy. 61(3). 26 indexed citations
19.
Gascón, Félix, et al.. (2001). Bacteriemia por Stomatococcus mucilaginosus en un paciente de riesgo. 50(3). 147–148. 3 indexed citations
20.
Prado, V, et al.. (1992). Enterohemorrhagic Escherichia coli associated with hemolytic-uremic syndrome in Chilean children. Journal of Clinical Microbiology. 30(8). 2153–2157. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026